Corporate Investor

Updated:

Hainan Xinzhaosheng Investment

Hainan Xinzhaosheng Investment is a corporate investor based in Haikou; the Altss profile covers its classification, headquarters, registration, AUM band, and...

Hainan Xinzhaosheng Investment logo

Hainan Xinzhaosheng Investment

Hainan Xinzhaosheng Investment is a corporate investor based in Haikou, China. It has invested in two funds. Its regional focus is Asia.

General information

Firm type

Corporate Investor

Year founded

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Haikou

Corporate office

Haikou, Hainan, China

Principals

Li Feng

Founder, Executive Director

Sector focus

Industrial TechBiotech & Life SciencesEnergy Transition & Renewables

Frequently asked questions

Who runs investment decisions at Hainan Xinzhaosheng Investment?

Li Feng (李峰) is the founder and controlling mind of the firm. Public records list him as the legal representative and executive director, a role that in Chinese corporate structures typically consolidates both strategic and investment authority. There is no indication of a separate investment committee or external delegated managers for internal decisions, though fund-level decisions in the Moutai Jinshi Biotech Industry Fund are executed alongside Jinshi Investment, which may supply separate investment professionals.

How is Hainan Xinzhaosheng related to Kweichow Moutai and Citic Securities?

Xinzhaosheng is a co-investor and co-sponsor in the Moutai Jinshi Biotech Industry Fund. Jinshi Investment — a subsidiary of Citic Securities — serves as the fund manager, while Xinzhaosheng participates as a strategic corporate partner. Kweichow Moutai's involvement comes through the fund's branding and capital, reflecting Moutai's push to diversify into biotech. Xinzhaosheng is not a subsidiary of either entity; it is a separate firm with Li Feng at the helm.

What sectors does Hainan Xinzhaosheng target in its biotech fund?

The Moutai Jinshi Biotech Industry Fund focuses on synthetic biology, biomanufacturing, and advanced biomaterials. These are sectors where China seeks to build domestic supply chains and reduce import dependence on precision fermentation inputs, bio-based chemicals, and industrial enzymes. The fund's structure suggests a bias toward commercial-stage startups ready to scale manufacturing rather than pure deep-science seed bets.

Does Hainan Xinzhaosheng invest outside of biotech?

Yes. Beyond the biotech fund, Xinzhaosheng has a demonstrated interest in energy storage infrastructure. Its known counterparty, China Anchu Energy Storage Group Limited, indicates direct or structured investments in grid-scale battery storage and related hardware. This dual-track approach — biotech and energy infrastructure — mirrors a broader Chinese corporate pattern of pairing fast-growth venture with hard-asset infrastructure.

Is Hainan Xinzhaosheng a state-owned entity?

No evidence suggests direct state ownership. The firm is structured as a corporate investor registered in Hainan, with Li Feng as the natural-person legal representative. Its partnerships with Citic Securities — a state-linked securities firm — and a fund bearing Moutai's name give it a policy-adjacent posture, but the vehicle itself appears to be privately controlled.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Haikou Corporate Investor profiles